Precision Medicine in Stroke

Precision Medicine in Stroke
Author: Ana Catarina Fonseca
Publisher: Springer Nature
Total Pages: 339
Release: 2021-05-04
Genre: Medical
ISBN: 303070761X

This book provides a comprehensive coverage of the state of the art in precision medicine in stroke. It starts by explaining and giving general information about precision medicine. Current applications in different strokes types (ischemic, haemorrhagic) are presented from diagnosis to treatment. In addition, ongoing research in the field (early stroke diagnosis and estimation of prognosis) is extensively discussed. The final part provides an in-depth discussion of how different interdisciplinary areas like artificial intelligence, molecular biology and genetics are contributing to this area. Precision Medicine in Stroke provides a practical approach to each chapter, reinforcing clinical applications and presenting clinical cases. This book is intended for all clinicians that interact with stroke patients (neurologists, internal medicine doctors, general practitioners, neurosurgeons), students and basic researchers.

1 - USE OF ARTIFICIAL INTELLIGENCE TO PREDICT VOLUME OF BRAIN AND INFARCTION GROWTH RATE; A STEP TOWARDS PRECISION MEDICINE

1 - USE OF ARTIFICIAL INTELLIGENCE TO PREDICT VOLUME OF BRAIN AND INFARCTION GROWTH RATE; A STEP TOWARDS PRECISION MEDICINE
Author: Saadat Kamran
Publisher:
Total Pages:
Release: 2017
Genre:
ISBN:

Background: Background. The final human brain infarction volume [IV] and infarction growth rate [IGR] are strong predictors of clinical outcome. IGR is dynamic with wide variations in speed of growth. The conventional mathematical techniques are unable to predict IV and IGR.Patients and Methods: In this, single-center, prospective study data was collected on all acute stroke patients treated by intravenous thrombolysis and/or mechanical thrombectomy between January 2014 and December 2016.Infarct Growth Rate calculation [IGR]. Infarct volumes were measured on the baseline and 24-hour CT. For IGR calculation we assumed the stroke volume to be zero prior to stroke onset.Infarct growth rate 1[IGR1] = u0394 volume (IV CT1u20130)/u0394 time (time CT1- stroke onset time)Second infarct growth rate [IGR2] was measured on second CT [CT2]IGR2 = u0394 volume/ u0394 time = (IV CT2- IV CT1)/ (time CT2-time CT1).To quantify the difference between the estimated IGR and actual IGR mean square error [MSE] was usedufffdufffdufffdufffdufffdufffd=1/ufffdufffd u2211128_(ufffdufffd=0)^(ufffdufffdu22121)u2592(u3016ufffdufffdufffdufffdufffdufffdu3017_(u3016ufffdufffdufffdufffdufffdufffdufffdufffdufffdufffdufffdufffdu3017_ufffdufffd )u2212u3016ufffdufffdufffdufffdufffdufffdu3017_(u3016ufffdufffdufffdufffdufffdufffdufffdufffdufffdufffdufffdufffdufffdufffdufffdufffdufffdufffdu3017_ufffdufffd ) )^2ResultsA total of 134 consecutive patients with an acute ischemic infarction secondary to middle cerebral artery occlusion were treated with a mean time to treatment from symptom onset of 213.27 +/- 227.12 minutes. A bivariate analysis showed the clot burden score [p=0.003], and time to treatment [p=0.78] was negatively/inversely correlated with IGR, while IGR 1 positively correlated with IGR2 [p=0.067]. The IGR2 was significantly higher when the collateral circulation score was low compared to a high score [p=0.001]. An unfavourable modified treatment in cerebral infarction (mTICI) score had a significantly higher IGR2 compared to those who had a favourable mTICI score [p=0.035] (Table 2 methods section). The demographics, clinical and radiological details are provided in the methods section [Table 2 methods section]. A comparison of ANFIS training and testing data [Table 3, methods section] showed no statistically significant difference except better collateral score [p=0.024] in the testing group with lower IGR2 [p=0.03]. The ANFIS based model was able to predict the IGR2 and infarction volume, calculated from the predicted IGR 2, without any statistically significant difference compared to the original data [p=0.001] [Figure 1, Table 2]. The mean square error was 8.95% with an accuracy of 91.05%. In addition, ANFIS-predicted values were in agreement with the original data as shown by skewness, cross-correlation and Cosine Similarity [Table 2].Conclusions : We showed an ANFIS based model to predict second brain IV [IV2] and second IGR [IGR2] depending on first imaging study, using prospectively collected data of acute stroke patients. The model predicted the IGR2 and IV2 without any significant difference to the original data [p=0.001]. We achieved an accuracy of 91.05% in predicting IV2 and IGR2 by combining demographic, clinical and radiological data and then applying ANFIS. Our study has the potential to help in more effective patient selection for treatment, particular therapies like extended hours thrombectomy and hemicraniectomy for malignant brain strokes and predict outcome in ischemic stroke, a step towards precision medicine.

Broken Movement

Broken Movement
Author: John W. Krakauer
Publisher: MIT Press
Total Pages: 288
Release: 2022-06-07
Genre: Medical
ISBN: 0262545837

An account of the neurobiology of motor recovery in the arm and hand after stroke by two experts in the field. Stroke is a leading cause of disability in adults and recovery is often difficult, with existing rehabilitation therapies largely ineffective. In Broken Movement, John Krakauer and S. Thomas Carmichael, both experts in the field, provide an account of the neurobiology of motor recovery in the arm and hand after stroke. They cover topics that range from behavior to physiology to cellular and molecular biology. Broken Movement is the only accessible single-volume work that covers motor control and motor learning as they apply to stroke recovery and combines them with motor cortical physiology and molecular biology. The authors cast a critical eye at current frameworks and practices, offer new recommendations for promoting recovery, and propose new research directions for the study of brain repair. Krakauer and Carmichael discuss such subjects as the behavioral phenotype of hand and arm paresis in human and non-human primates; the physiology and anatomy of the motor system after stroke; mechanisms of spontaneous recovery; the time course of early recovery; the challenges of chronic stroke; and pharmacological and stem cell therapies. They argue for a new approach in which patients are subjected to higher doses and intensities of rehabilitation in a more dynamic and enriching environment early after stroke. Finally they review the potential of four areas to improve motor recovery: video gaming and virtual reality, invasive brain stimulation, re-opening the sensitive period after stroke, and the application of precision medicine.

Precision Medicine in Cardiovascular Disease Prevention

Precision Medicine in Cardiovascular Disease Prevention
Author: Seth S. Martin
Publisher: Springer Nature
Total Pages: 194
Release: 2021-07-07
Genre: Medical
ISBN: 3030750558

This book contains the current knowledge and potential future developments of precision medicine techniques including artificial intelligence, big data, mobile health, digital health and genetic medicine in the prevention of cardiovascular disease. It reviews the presently used advanced precision medicine techniques and fundamental principles that continue to act as guiding forces for many medical professionals in applying precision and preventative medical techniques in their day-to-day practices. Precision Medicine in Cardiovascular Disease Prevention describes current knowledge and potential future developments in this rapidly expanding field. It therefore provides a valuable resource for all practicing and trainee cardiologists looking to develop their knowledge and integrate precision medicine techniques into their practices.

Genomic and Precision Medicine

Genomic and Precision Medicine
Author: Geoffrey S. Ginsburg
Publisher: Academic Press
Total Pages: 379
Release: 2022-04-09
Genre: Science
ISBN: 0128006536

Genomic and Precision Medicine: Oncology, Third Edition focuses on the applications of genome discovery as research points to personalized cancer therapies. Each chapter is organized to cover the application of genomics and personalized medicine tools and technologies to a) Risk Assessment and Susceptibility, b) Diagnosis and Prognosis, c) Pharmacogenomics and Precision Therapeutics, and d) Emerging and Future Opportunities in the field. Provides a comprehensive volume written and edited by oncology genomic specialists for oncology health providers Includes succinct commentary and key learning points that will assist providers with their local needs for implementation of genomic and personalized medicine into practice Presents an up-to-date overview on major opportunities for genomic and personalized medicine in practice Covers case studies that highlight the practical use of genomics in the management of patients

Genomic and Precision Medicine

Genomic and Precision Medicine
Author: Geoffrey S. Ginsburg
Publisher: Academic Press
Total Pages: 372
Release: 2017-03-30
Genre: Science
ISBN: 0128006544

Genomic and Precision Medicine: Primary Care, Third Edition is an invaluable resource on the state-of-the-art tools, technologies and policy issues that are required to fully realize personalized health care in the area of primary care. One of the major areas where genomic and personalized medicine is most active is the realm of the primary care practitioner. Risk, family history, personal genomics and pharmacogenomics are becoming increasingly important to the PCP and their patients, and this book discusses the implications as they relate to primary care practitioners. Presents a comprehensive volume for primary care providers Provides succinct commentary and key learning points that will assist providers with their local needs for the implementation of genomic and personalized medicine Includes a current overview on major opportunities for genomic and personalized medicine in practice Highlights case studies that illustrate the practical use of genomics in the management in patients

Stroke Genetics

Stroke Genetics
Author: Hugh S. Markus
Publisher: Oxford Medical Publications
Total Pages: 362
Release: 2003
Genre: Medical
ISBN: 0198515863

Stroke is a major cause of death and the major cause of adult neurological disability in most of the world. Despite its importance on a population basis, research into the genetics of stroke has lagged behind that of many other disorders. However, the situation is now changing. Anincreasing number of single gene disorders causing stroke are being described, and there is growing evidence that polygenic factors are important in the risk of apparently "sporadic" stroke.Stroke Genetics provides an up-to-date review of the area, suitable for clinicians treating stroke patients, and both clinical and non-clinical researchers in the field of cerebrovascular disease. The full range of monogenic stroke disorders causing cerebrovascular disease, including ischaemicstroke, intracerebral haemorrhage, aneurysms and arteriovenous malformations, are covered. For each, clinical features, diagnosis, and genetics are described. Increasing evidence suggest that genetic factors are also important for the much more common multifactorial stroke; this evidence isreviewed along with the results of genetic studies in this area. Optimal and novel strategies for investigating multifactorial stroke, including the use of intermediate phenotypes such as intima-media thickness and MRI detected small vessel disease are reviewed. The book concludes by describing apractical approach to investigating patients with stroke for underlying genetic disorders. Also included is a list of useful websites.

Economic Dimensions of Personalized and Precision Medicine

Economic Dimensions of Personalized and Precision Medicine
Author: Ernst R. Berndt
Publisher: University of Chicago Press
Total Pages: 361
Release: 2019-04-22
Genre: Business & Economics
ISBN: 022661123X

Personalized and precision medicine (PPM)—the targeting of therapies according to an individual’s genetic, environmental, or lifestyle characteristics—is becoming an increasingly important approach in health care treatment and prevention. The advancement of PPM is a challenge in traditional clinical, reimbursement, and regulatory landscapes because it is costly to develop and introduces a wide range of scientific, clinical, ethical, and socioeconomic issues. PPM raises a multitude of economic issues, including how information on accurate diagnosis and treatment success will be disseminated and who will bear the cost; changes to physician training to incorporate genetics, probability and statistics, and economic considerations; questions about whether the benefits of PPM will be confined to developed countries or will diffuse to emerging economies with less developed health care systems; the effects of patient heterogeneity on cost-effectiveness analysis; and opportunities for PPM’s growth beyond treatment of acute illness, such as prevention and reversal of chronic conditions. This volume explores the intersection of the scientific, clinical, and economic factors affecting the development of PPM, including its effects on the drug pipeline, on reimbursement of PPM diagnostics and treatments, and on funding of the requisite underlying research; and it examines recent empirical applications of PPM.

Genomic and Precision Medicine

Genomic and Precision Medicine
Author: Geoffrey S. Ginsburg
Publisher: Academic Press
Total Pages: 337
Release: 2017-11-17
Genre: Science
ISBN: 0128018259

Genomic and Precision Medicine: Cardiovascular Disease, Third Edition, focuses on the applications of genome discovery on the broad spectrum of cardiovascular disorders. Each chapter is organized for the application of genomics and personalized medicine tools and technologies to a) Risk Assessment and Susceptibility, b) Diagnosis and Prognosis, c) Pharmacogenomics and Precision Therapeutics, and d) Emerging and Future Opportunities in the field. Presents a comprehensive volume written and edited by cardiovascular genomic specialists Covers succinct commentary and key learning points that will assist providers with their local needs for the implementation of genomic and personalized medicine into practice Provides an overview on major opportunities for genomic and personalized medicine in practice Includes case studies that highlight the practical use of genomics in the management of patients